Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type 1 diabetes.

A Lernmark1

  • 1R.H. Williams Laboratory, University of Washington, 1959 N.E. Pacific St., Room K-165, HSB, Seattle, WA 98195, USA. ake@uwashington.edu

Clinical Chemistry
|August 3, 1999
PubMed
Summary
This summary is machine-generated.

Type 1 diabetes involves genetic and environmental factors, leading to islet beta-cell autoimmunity. Autoantibody testing, combined with genetic screening, improves prediction and classification of diabetes, aiding intervention trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

The Better Diabetes Diagnosis (BDD) study - A review of a nationwide prospective cohort study in Sweden.

Diabetes research and clinical practice·2018
Same author

Different DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease.

HLA·2017
Same author

Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA).

Clinical and experimental immunology·2016
Same author

Pancreas volume and fat fraction in children with Type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Genes and immunity·2015
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • Type 1 diabetes is a global autoimmune disease affecting islet beta cells.
  • Genetic susceptibility involves HLA genes and other chromosomal factors.
  • Environmental triggers, such as infections, are implicated in disease initiation and progression.

Purpose of the Study:

  • To explore the role of genetic and environmental factors in Type 1 diabetes pathogenesis.
  • To evaluate the diagnostic utility of islet autoantibodies in Type 1 diabetes.
  • To assess the potential of combined genetic and autoantibody screening for disease prediction and classification.

Main Methods:

  • Analysis of genetic susceptibility loci, including HLA-DQ, HLA-DR, insulin gene, and cytotoxic T-lymphocyte antigen gene.

Related Experiment Videos

  • Development and standardization of molecular assays for autoantibodies against glutamic acid decarboxylase, insulin, and islet cell antigen-2.
  • Evaluation of diagnostic sensitivity and specificity of autoantibodies for Type 1 diabetes.
  • Assessment of autoantibody positivity in predicting disease in relatives and its relation to metabolic control.

    • Main Results:

    • High diagnostic specificity (99%) and sensitivity (40-80%) for Type 1 diabetes using autoantibodies.
    • Double or triple autoantibody positivity predicts disease in first-degree relatives.
    • Combined genetic and autoantibody testing enhances prediction in the general population.
    • Autoantibody testing improves diabetes classification and predicts insulin requirement in Type 2 diabetes.

    Conclusions:

    • Islet autoantibodies are key markers for Type 1 diabetes autoimmunity and prediction.
    • Combined genetic and autoantibody screening offers a rational approach for identifying individuals for intervention trials.
    • Autoantibody testing aids in understanding residual beta-cell function and metabolic control.